Catalyst Wire Dossier Catalyst Wire Dossier

Autogene Cevumeran

autogene cevumeran
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Autogene Cevumeran, covering 2025-07-04 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC [Phase 2]

See pricing